Findings
vomiting
SECONDARY
In this secondary analysis involving 705 patients in a randomized clinical trial, complete response (defined as no vomiting and no use of rescue medication) in the delayed phase (24-120 hours after cisplatin-based chemotherapy initiation) was significantly greater in the olanzapine group than the placebo group, regardless of the presence or absence of risk factors.